Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 11 |
GO:0042995 | cell projection | 2 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 11 |
GO:0005930 | axoneme | 2 | 1 |
Related structures:
AlphaFold database: A4H5Z9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.388 |
DEG_APCC_DBOX_1 | 51 | 59 | PF00400 | 0.550 |
DOC_CDC14_PxL_1 | 142 | 150 | PF14671 | 0.360 |
DOC_CKS1_1 | 158 | 163 | PF01111 | 0.594 |
DOC_CYCLIN_RxL_1 | 146 | 154 | PF00134 | 0.424 |
DOC_MAPK_gen_1 | 98 | 107 | PF00069 | 0.388 |
DOC_MAPK_MEF2A_6 | 189 | 197 | PF00069 | 0.558 |
DOC_MAPK_MEF2A_6 | 204 | 211 | PF00069 | 0.597 |
DOC_PP1_RVXF_1 | 76 | 82 | PF00149 | 0.425 |
DOC_PP2B_LxvP_1 | 143 | 146 | PF13499 | 0.314 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.563 |
DOC_USP7_MATH_1 | 199 | 203 | PF00917 | 0.571 |
DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 67 | 72 | PF00397 | 0.676 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.674 |
LIG_14-3-3_CanoR_1 | 104 | 108 | PF00244 | 0.382 |
LIG_14-3-3_CanoR_1 | 149 | 154 | PF00244 | 0.424 |
LIG_14-3-3_CanoR_1 | 65 | 73 | PF00244 | 0.663 |
LIG_Actin_WH2_2 | 75 | 92 | PF00022 | 0.665 |
LIG_BRCT_BRCA1_1 | 35 | 39 | PF00533 | 0.696 |
LIG_Clathr_ClatBox_1 | 12 | 16 | PF01394 | 0.456 |
LIG_CSL_BTD_1 | 113 | 116 | PF09270 | 0.424 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.664 |
LIG_FHA_2 | 158 | 164 | PF00498 | 0.630 |
LIG_FHA_2 | 221 | 227 | PF00498 | 0.672 |
LIG_LIR_Gen_1 | 188 | 199 | PF02991 | 0.508 |
LIG_LIR_Gen_1 | 205 | 212 | PF02991 | 0.569 |
LIG_LIR_Gen_1 | 85 | 92 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 113 | 117 | PF02991 | 0.396 |
LIG_LIR_Nem_3 | 188 | 194 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 196 | 200 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 5 | 9 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 85 | 89 | PF02991 | 0.529 |
LIG_MAD2 | 149 | 157 | PF02301 | 0.449 |
LIG_PCNA_yPIPBox_3 | 101 | 115 | PF02747 | 0.449 |
LIG_Pex14_2 | 35 | 39 | PF04695 | 0.705 |
LIG_PTB_Apo_2 | 153 | 160 | PF02174 | 0.424 |
LIG_PTB_Phospho_1 | 153 | 159 | PF10480 | 0.449 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.545 |
LIG_SH2_CRK | 9 | 13 | PF00017 | 0.452 |
LIG_SH2_SRC | 172 | 175 | PF00017 | 0.658 |
LIG_SH2_STAP1 | 191 | 195 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.699 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.598 |
LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.575 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.638 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.561 |
LIG_SH3_3 | 1 | 7 | PF00018 | 0.634 |
LIG_SUMO_SIM_anti_2 | 53 | 59 | PF11976 | 0.570 |
LIG_SUMO_SIM_par_1 | 149 | 154 | PF11976 | 0.338 |
LIG_TRAF2_1 | 124 | 127 | PF00917 | 0.338 |
LIG_TRAF2_1 | 160 | 163 | PF00917 | 0.680 |
LIG_WRC_WIRS_1 | 194 | 199 | PF05994 | 0.540 |
MOD_CDK_SPK_2 | 67 | 72 | PF00069 | 0.676 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.667 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.530 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.621 |
MOD_CK2_1 | 220 | 226 | PF00069 | 0.655 |
MOD_CK2_1 | 97 | 103 | PF00069 | 0.553 |
MOD_GlcNHglycan | 180 | 184 | PF01048 | 0.670 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.588 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.559 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.570 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.671 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.657 |
MOD_N-GLC_1 | 39 | 44 | PF02516 | 0.703 |
MOD_N-GLC_1 | 82 | 87 | PF02516 | 0.515 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.579 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.515 |
MOD_NEK2_2 | 29 | 34 | PF00069 | 0.674 |
MOD_PKA_2 | 64 | 70 | PF00069 | 0.594 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.621 |
MOD_PKA_2 | 97 | 103 | PF00069 | 0.557 |
MOD_PKB_1 | 147 | 155 | PF00069 | 0.449 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.529 |
MOD_Plk_1 | 92 | 98 | PF00069 | 0.566 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.449 |
MOD_Plk_4 | 168 | 174 | PF00069 | 0.609 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.388 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.610 |
MOD_ProDKin_1 | 157 | 163 | PF00069 | 0.577 |
MOD_ProDKin_1 | 67 | 73 | PF00069 | 0.673 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.675 |
MOD_SUMO_rev_2 | 162 | 167 | PF00179 | 0.458 |
TRG_ENDOCYTIC_2 | 190 | 193 | PF00928 | 0.513 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.526 |
TRG_ENDOCYTIC_2 | 9 | 12 | PF00928 | 0.452 |
TRG_ER_diArg_1 | 146 | 149 | PF00400 | 0.449 |
TRG_ER_diArg_1 | 221 | 224 | PF00400 | 0.643 |
TRG_Pf-PMV_PEXEL_1 | 123 | 127 | PF00026 | 0.303 |
TRG_Pf-PMV_PEXEL_1 | 149 | 154 | PF00026 | 0.424 |
TRG_Pf-PMV_PEXEL_1 | 24 | 28 | PF00026 | 0.478 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7B1 | Leptomonas seymouri | 62% | 100% |
A0A0S4J897 | Bodo saltans | 45% | 82% |
A0A1X0NQ44 | Trypanosomatidae | 54% | 100% |
A0A3S7WQZ4 | Leishmania donovani | 83% | 99% |
A0A422NRS7 | Trypanosoma rangeli | 54% | 100% |
A4HUC5 | Leishmania infantum | 84% | 99% |
C9ZVG5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9AN24 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 99% |
Q01730 | Mus musculus | 30% | 85% |
Q15404 | Homo sapiens | 30% | 85% |
Q32NT4 | Xenopus laevis | 25% | 67% |
Q4QHK2 | Leishmania major | 81% | 100% |
Q5E9C0 | Bos taurus | 30% | 85% |
V5BIH6 | Trypanosoma cruzi | 54% | 100% |